India's most comprehensive portal on pharmaceutical News, Tenders, Patents, Notifications, Projects, Stocks, Drugs & Medicines

US FDA places clinical hold on Astellas’ FORTIS trial of AT845 in adults with late-onset pompe disease

Join Pharma | Login

	Editorial


	AN AMBITIOUS TARGET TO END AIDS
	Wednesday, June 22, 2022
	Governments of over 190 nations, including India, have pledged to end AIDS by 2030 by adopting the UN Sustainable Development Goals.
	Past Editorial...

TODAY'S NEWS


12:00 [IST]	US FDA places clinical hold on Astellas’ FORTIS trial of AT845 in adults with late-onset pompe disease
11:00 [IST]	Ipsen to acquire biopharmaceutical company, Epizyme
10:00 [IST]	New Novartis extension phase data show nearly 80% of RMS patients treated with Kesimpta had no evidence of disease activity
09:00 [IST]	EU CHMP recommends approval of Lynparza as adjuvant treatment for germline BRCA-mutated, HER2-negative high-risk early breast cancer

more news >>

TOP NEWS


08:00 [IST]	PCI expects security deposit from institutions to act as safety net for students and teachers
08:00 [IST]	AKCDA appeals to traders to boycott corporate entities in medical business
08:00 [IST]	Industry eyes 3D printing for manufacture as the future to spur easy fabrication of tablets with multiple APIs
08:00 [IST]	Clirnet targets to grow doctor base to 300,000+ by year end
08:00 [IST]	Dermatology sector set to boom in the post Covid-19 market
08:00 [IST]	High input costs continue taking a toll on drug manufacturers

more news >>

YESTERDAY'S NEWS


18:00 [IST]	Teva presents positive interim results from PEARL study of Ajoy in patients with chronic migraine or episodic migraine at EAN congress
17:00 [IST]	Researchers find oral antiviral drug that could provide an effective treatment against respiratory syncytial virus
16:00 [IST]	WHO publishes updated guidance on hepatitis C infection – with new recommendations on treatment of adolescents and children, simplified service delivery and diagnostics
15:00 [IST]	Harrow Health introduces Iopidine 1% and Maxitrol in US markets
14:30 [IST]	US FDA accepts Emergent BioSolutions’ BLA for AV7909 anthrax vaccine candidate
14:00 [IST]	Intellia, Regeneron announce positive interim data from phase 1 study of CRISPR-based NTLA-2001 to treat transthyretin amyloidosis

more news >>

INTERVIEW


Pharmexcil to explore export promotion opportunities for pharma exporters by holding B2B and BSM meets
S V Veeramani, president of Indian Drug Manufacturers’ Association (IDMA)

Past Interviews...

	What's New?

Supply Of Homoeopathic / Ayurvedic Medicines Procurement Of 6 Mt Of Anti Oxidant Ao6 Af Stabilizer For Gail Pata Rate Contract For Supply Of Surgical Items Procurement Of Medical Gases For Central Hospital, Kalla Proposal For Purchase Of H1n1 Influenza Virus Kit, Cat. No. 3b243, Make: Kilpest India Ltd. On Proprietary Basis

Opinion Poll

Will the new D Pharm syllabus published by PCI adequate to create next-gen pharmacists?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers